首頁 > 市場調查報告書 > 製藥

處方藥疼痛

市場調查報告書

商品編碼

1550554

止痛藥的全球市場：按藥物類型、按給藥途徑、按應用、按疼痛類型、按分銷管道、按地區

Global Analgesics Market, By Drug Type, By Route of Administration, By Application, By Pain Type, By Distribution Channel, By Geography

出版日期: 2024年07月30日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球止痛藥市場規模將達511億美元，2024年至2031年複合年成長率為6.5%，2031年將達795.1億美元。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	511億美元
實際資料	2019-2023	預測期	2024-2031
預測 2024-2031 年複合年成長率：	6.50%	2031 年金額預測	795.1億美元

圖：2024 年按地區分類的止痛藥全球市場佔有率(%)

全球止痛藥市場的成長是由世界各地慢性和急性疼痛疾病的增加所推動的。鎮痛藥在緩解疼痛和改善患者生活品質方面發揮重要作用。生活方式的改變和壓力水平的增加導致背痛、關節炎和偏頭痛等與疼痛相關的疾病顯著增加。藥物輸送系統和製劑開發的技術進步正在增加對具有更高療效和降低成癮風險的新型止痛藥的需求。此外，老年人口的增加，更容易患骨關節炎和肌肉骨骼疾病，也是推動止痛藥需求的因素。然而，圍繞鴉片類藥物的嚴格監管和替代療法的開發可能給行業相關人員帶來挑戰。

市場動態：

全球止痛藥市場的成長主要是由於全球老年人口的不斷增加，導致關節炎、下背痛、偏頭痛和骨質疏鬆症等各種與疼痛相關的慢性疾病的盛行率不斷上升。據估計，到 2030 年，世界上超過 20% 的人口將受到骨關節炎的影響。久坐工作和壓力增加等生活方式的改變顯著增加了肌肉骨骼疾病的發生率，從而推動了對止痛藥的需求。然而，對處方鴉片類藥物濫用和濫用的日益擔憂可能會阻礙市場成長。這導致監管機構收緊了鴉片類止痛藥的核准和使用規則。此外，大麻素藥物、針灸和物理治療等替代療法越來越受歡迎，這可能會抑制對傳統止痛藥的需求。慢性疼痛管理的優惠報銷政策為止痛藥製造商提供了商機。繼續研究開發非成癮配方和先進的藥物輸送系統可能會提供未來的成長機會。

本研究的主要特點

該報告對全球止痛藥市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球止痛藥市場的主要企業。

主要公司包括輝瑞（Pfizer）、葛蘭素史克（GSK）、諾華（Novartis）和強生（Johnson & Johnson）。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球止痛市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球止痛藥市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- F. Hoffmann-La Roche Ltd.
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck &Co., Inc.
- AstraZeneca
- Johnson &Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin

第12章分析師建議

命運之輪
分析師觀點
一致的機會圖

第13章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI7207

Global analgesics market is estimated to be valued at USD 51.10 Bn in 2024 and is expected to reach USD 79.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 51.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	6.50%	2031 Value Projection:	US$ 79.51 Bn

Figure. Global Analgesics Market Share (%), By Region 2024

Global analgesics market growth is driven by rising prevalence of chronic and acute pain disorders worldwide. Analgesics drugs play a crucial role in relieving pain and enhancing the quality of life of patients. Changing lifestyles and higher stress levels have significantly increased several pain-related ailments like backache, arthritis, and migraines among others. Technological advancements in drug delivery systems and formulation development have boosted demand for novel analgesic medications with improved efficacy and reduced risk of addiction. Moreover, growing geriatric population prone to osteoarthritis and musculoskeletal disorders can also boost demand for analgesics. However, strict regulations surrounding opioid medications and development of alternative therapies can pose challenges to industry players.

Market Dynamics:

Global analgesics market growth is primarily driven by rising prevalence of various pain-related chronic conditions like arthritis, back pain, migraines, and osteoporosis due to growing geriatric population worldwide. As per estimates, over 20% of the global population will suffer from osteoarthritis by 2030. Changing lifestyles with sedentary jobs and increased stress levels have substantially raised the incidence of musculosketal disorders, thus, boosting demand for analgesic. However, growing concerns over misuse and abuse of prescription opioids can hamper the market growth. This has led regulatory bodies to tighten rules surrounding opioid analgesic approvals and usage. Moreover, alternative therapies like cannabinoid-based drugs, acupuncture, and physiotherapy are gaining popularity, and this can hamper demand for traditional painkillers. Favorable reimbursement policies for chronic pain management provides profitable opportunities for analgesic manufacturers. Ongoing research towards develop non-addictive formulas and advanced drug delivery systems can offer growth opportunities in the future.

Key Features of the Study:

This report provides in-depth analysis of the global analgesics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global analgesics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, GSK, Novartis, and Johnson & Johnson.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global analgesics market

Detailed Segmentation-

By Drug Type
- Opioid
- Non-opioid
- Compound medication
By Route of Administration
- Oral
- Parenteral
- Transdermal
- Others
By Application
- Musculoskeletal
- Surgical and Trauma
- Cancer
- Neuropathic
- Migraine
- Obstetrical
- Fibromyalgia
- Pain due to Burns
- Dental/Facial
- Pediatric
- Others
By Pain Type
- Acute
- Chronic
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Pain Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Analgesics Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Analgesics Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Opioid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Non-opioid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Compound medication
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Analgesics Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Analgesics Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Musculoskeletal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Surgical and Trauma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neuropathic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Migraine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Obstetrical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Fibromyalgia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pain due to Burns
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Dental/Facial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pediatric
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Analgesics Market, By Pain Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Acute
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Chronic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Analgesics Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

10. Global Analgesics Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
Europe
Asia Pacific
Middle East

11. Competitive Landscape

Company Profiles
- F. Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin